Clinical Trials Browser

Phase NA × Hodgkin Disease × Alemtuzumab × Clear all

NCT00578539 2016-04-22

REGALE

Phase NA Terminated

24 enrolled 7 charts

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders